Identifying Predictors Of Response To Mepolizumab In CRSwNP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Identifying Predictors Of Response To Mepolizumab In CRSwNP — Stella

Home/Chronic Rhinosinusitis With Nasal Polyps/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Rhinosinusitis With Nasal Polyps trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Canada

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec

Key details

Phase

Post-approval study

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment target

~36 participants

Started

October 2023

Primary completion

December 2026

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.